Achieving these outcomes with a second obesity medication may indicate a broader efficacy trend for pairing these 2 classes of medications. A team of investigators from the Division of Endocrinology at Mayo Clinic conducted a real-world study to determine if concurrent menopause hormone therapy enhances the effectiveness of tirzepatide for weight loss in postmenopausal women
Tirzepatide is also under regulatory review for weight management in Europe, China, the United Kingdom and several additional markets.
You should also consult your healthcare provider if thirst persists despite adequate fluid intake and good blood glucose control, or if you develop signs of hypoglycaemia (blood glucose below 4 mmol/L), including trembling, sweating, confusion, or palpitations
03 Ongoing Support Youre never alone on your weight loss journey
Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring
To determine if tirzepatide is right for you, well conduct a personalized consultation, evaluating your medical history, current condition, and goals for treatment